Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV

Journal of Clinical Investigation

Volumn 122, Issue 3, 2012, Pages 1076-1081

  Jones, Tiffany ^a,b   Ye, Fengchun ^a   Bedolla, Roble ^a   Huang, Yufei ^a,c   Meng, Jia ^c   Qian, Liwu ^a   Pan, Hongyi ^a   Zhou, Fuchun ^a   Moody, Rosalie ^a   Wagner, Brent ^d   Arar, Mazen ^a   Gao, Shou Jiang ^a,b,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c The University of Texas at San Antonio   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LATENT VIRUS INFECTION; LYMPH VESSEL ENDOTHELIUM; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; RAT; TUMOR; TUMOR CELL; TUMOR GROWTH; VASCULAR ENDOTHELIUM; VIRION; VIRUS INFECTION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CELL TRANSFORMATION, VIRAL; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HERPESVIRUS 8, HUMAN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; MICROCIRCULATION; OPEN READING FRAMES; RATS; TIME FACTORS;

EID: 84863274559     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI58530     Document Type: Article

References (30)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-3044.
2. Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest. 2010;120(4):939-949.
3. Ciufo DM, et al. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol. 2001;75(12):5614-5626. (Pubitemid 32488155)
4. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 1998;394(6693):588-592. (Pubitemid 28366835)
5. Gao SJ, Deng JH, Zhou FC. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J Virol. 2003;77(18):9738-9749.
6. Moses AV, et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol. 1999;73(8):6892-6902. (Pubitemid 29327872)
7. Carroll PA, Brazeau E, Lagunoff M. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology. 2004;328(1):7-18. (Pubitemid 39221907)
8. Hong YK, et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet. 2004;36(7):683-685.
9. Lagunoff M, et al. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J Virol. 2002;76(5):2440-2448. (Pubitemid 34150712)
10. Wang HW, et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet. 2004;36(7):687-693.
11. An FQ, et al. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol. 2006;80(10):4833-4846.
12. Massarelli G, Scott CA, Ibba M, Tanda F, Cossu A. Immunocytochemical profile of Kaposi's sarcoma cells: their reactivity to a panel of antibodies directed against different tissue cell markers. Appl Pathol. 1989;7(1):34-41. (Pubitemid 19090705)
13. Browning PJ, et al. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood. 1994;84(8):2711-2720. (Pubitemid 24317404)
14. Parsons CH, Szomju B, Kedes DH. Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus. Blood. 2004;104(9):2736-2738. (Pubitemid 39434955)
15. Wu W, et al. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood. 2006;108(1):141-151. (Pubitemid 43990622)
16. Mutlu AD, et al. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell. 2007;11(3):245-258. (Pubitemid 46357638)
17. Zhou FC, et al. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol. 2002;76(12):6185-6196.
18. Aluigi MG, et al. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. Res Virol. 1996;147(5):267-275. (Pubitemid 26276045)
19. Lebbe C, et al. Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon. Arch Dermatol Res. 1997;289(7):421-428. (Pubitemid 27331337)
20. Nakamura S, et al. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science. 1988;242(4877):426-430.
21. Salahuddin SZ, et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science. 1988;242(4877):430-433.
22. Fina L, et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75(12):2417-2426. (Pubitemid 20202322)
23. Pont S. Thy-1: a lymphoid cell subset marker capable of delivering an activation signal to mouse T lymphocytes. Biochimie. 1987;69(4):315-320.
24. Abeysinghe HR, et al. THY1 expression is associated with tumor suppression of human ovarian cancer. Cancer Genet Cytogenet. 2003;143(2):125-132. (Pubitemid 36629319)
25. Nishinakamura R, Uchiyama Y, Sakaguchi M, Fujimura S. Nephron progenitors in the metanephric mesenchyme. Pediatr Nephrol. 2011;26(9):1463-1467.
26. Usui J, Yamada R, Kanemoto K, Koyama A, Nagata M. Murine metanephric mesenchyme possesses characteristics of vascular endothelial cells in vitro. Nephron Exp Nephrol. 2006;102(3-4):e93-e98. (Pubitemid 43289533)
27. Arar M, Xu YC, Elshihabi I, Barnes JL, Choudhury GG, Abboud HE. Platelet-derived growth factor receptor beta regulates migration and DNA synthesis in metanephric mesenchymal cells. J Biol Chem. 2000;275(13):9527-9533. (Pubitemid 30185182)
28. Wagner B, et al. Mitogenic signaling via platelet-derived growth factor beta in metanephric mesenchymal cells. J Am Soc Nephrol. 2007;18(11):2903-2911. (Pubitemid 350058397)
29. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene. 1997;15(16):1979-1985. (Pubitemid 27480686)
30. Ye FC, et al. Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. J Virol. 2007;81(8):3980-3991.